Sadahiro Kamiya

Main subjects

･Advanced Biopharmaceuticals ･Medical Pharmacy Seminar

Research Themes and Keywords

Research on cell differentiation (osteoclasts, osteoblasts, etc.)

Final academic background/degree

Tokyo University of Science/Doctor

licence · Qualification

pharmacist

Affiliated academic society

The Pharmaceutical Society of Japan, The Japanese Society of Bone and Metabolism, The Japanese Society for Immunology

Major achievements

1. Suzuki H, Sasada M, Kamiya S, Ito Y, Watanabe H, Okada Y, Ishibashi K, Iyoda T, Yanaka A, Fukai F. The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration. Int J Mol Sci. 2017 Jan 17;18(1):181.
2. Kamiya S, Okumura M, Chiba Y, Fukawa T, Nakamura C, Nimura N, Mizuguchi J, Wada S, Yoshimoto T. IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3. Immunol Lett. 2011 Jul; 138(1):47-53.
3. Kamiya S, Nakamura C, Fukawa T, Ono K, Ohwaki T, Yoshimoto T, Wada S. Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation. J Bone Miner Metab. 2007; 25(5):277-85.

For more details on Research please click here.